COVID-19 outcomes and vaccination in people with relapsing multiple sclerosis treated with ofatumumab
Abstract Introduction The SARS-CoV-2 pandemic necessitated better understanding of the
impact of disease-modifying therapies on COVID-19 outcomes and vaccination. We report …
impact of disease-modifying therapies on COVID-19 outcomes and vaccination. We report …
COVID-19: the course, vaccination and immune response in people with multiple sclerosis: systematic review
M Bazylewicz, M Gudowska-Sawczuk… - International Journal of …, 2023 - mdpi.com
When the Coronavirus Disease 2019 (COVID-19) appeared, it was unknown what impact it
would have on the condition of patients with autoimmunological disorders. Attention was …
would have on the condition of patients with autoimmunological disorders. Attention was …
Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies
L Prosperini, C Tortorella, S Haggiag, S Ruggieri… - Journal of …, 2022 - Springer
Objective To identify risk factors for an increased lethality of COVID-19 in patients with
multiple sclerosis (MS). Methods We searched scientific databases to identify cohort studies …
multiple sclerosis (MS). Methods We searched scientific databases to identify cohort studies …
Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies
L Prosperini, C Tortorella, S Haggiag, S Ruggieri… - Journal of …, 2021 - Springer
Objective To estimate whether the risk of death from COVID-19 in patients with multiple
sclerosis (MS) exceeds that of the general population. Methods We conducted a pooled …
sclerosis (MS) exceeds that of the general population. Methods We conducted a pooled …
The disease course of multiple sclerosis before and during COVID-19 pandemic: a retrospective five-year study
F Babtain, A Bajafar, O Nazmi, M Badawi… - Multiple Sclerosis and …, 2022 - Elsevier
Introduction COVID-19 pandemic is thought to influence the natural history of immune
disorders, yet the knowledge on its effect on multiple sclerosis (MS) is unknown and not fully …
disorders, yet the knowledge on its effect on multiple sclerosis (MS) is unknown and not fully …
Distinct Clinical Manifestations of COVID-19 in Multiple Sclerosis Patients: Unraveling the Clinical Nexus
A Aboofazeli, M Mondeali, R Tajdini… - Archives of …, 2024 - brieflands.com
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is a
virus in the coronaviridae, has caused a global pandemic with various symptoms and …
virus in the coronaviridae, has caused a global pandemic with various symptoms and …
[PDF][PDF] COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab
AHCSD Mario, HMDBJ Ward, BACCNT Ratnakar… - 2022 - scienceopen.com
ABSTRACT Introduction: The SARS-CoV-2 pandemic necessitated better understanding of
the impact of disease-modifying therapies on COVID-19 outcomes and vaccination. We …
the impact of disease-modifying therapies on COVID-19 outcomes and vaccination. We …